Search Results

Renal Artery Stenosis and Renal Insufficiency

Weigh individual risks and benefits to determine whether revascularization will improve kidney function.

By DAVID J. SPINOSA, MD, AND KENNETH ROSENFIELD, MD

The Future of DVT Therapy

Examining the origin and current state of treatment to predict the future of DVT.

By David W. Hunter, MD, and Karen J. Kowalik, RN, MBA

Why Extravascular Closure?

The Baptist Memorial Hospital Experience with the Mynx¨ Vascular Closure Device.

By David Wolford, MD, FACC

Novel Vascular Access Management

The Boomerang system facilitates manual compression while leaving nothing behind.

By David E. Allie, MD; Ron Smalling, MD; Chris J. Hebert, RT, R-CIS; and Craig M. Walker, MD

STEP: A Platform Trial for Stroke Thrombectomy

The rationale and status of the StrokeNet endovascular thrombectomy platform proposal.

By Colin Derdeyn, MD; J Mocco, MD, MS; Tudor G. Jovin, MD; and Caitlyn Meinzer, PhD

Outpatient Interventional Oncology: Primum Non Nocere

Top tips for treating patients and avoiding complications in the outpatient setting.

By Edgar D. St. Amour, MD; David Hays, MD; and Ripal T. Gandhi, MD, FSIR, FSVM

Simulation Training in 2005

In the near future, simulation training will have a significant impact on the way we learn to execute new procedures.

By James A.M. Smith, DO, and David H. Deaton, MD

The Role of Interventional Oncology in Multidisciplinary Tumor Boards

An analysis of the interventional oncologist's impact on cancer patient care as part of a multidisciplinary tumor board.

By David M. Liu, MD, FRCP(C), FSIR

Where Will the Vascular Interventions of the Future Be Performed in the US?

Insights into the evolving landscape of care locations and facility types.

With Ehrin J. Armstrong, MD, MSc, MAS, FACC, FSCAI, FSVM; Sonya Noor, MD, FACS; Mary Costantino, MD; and David M. Mauro, MD

Essential Innovation and Clinical Trial Needs in Vascular Care

Experts from a variety of specialty backgrounds comment on hurdles and opportunities for future clinical trials to explore.

With Kendal M. Endicott, MD; Jessica P. Simons, MD, MPH; Abinaya Ramakrishnan, BA; Salma Youssef; Mona Ranade, MD; John M. Moriarty, MD, FSIR; Peter A. Schneider, MD; Amy C. Taylor, MD; Sarah B. White, MD, MS, FSIR, FCIRSE; Stephen A. Black, MD, FRCS(Ed), FEBVS; Kunal P. Raygor, MD; Mehdi Bouslama, MD, MSc; and Elad I. Levy, MD, MBA

Adopting New DVT Tools: What Are the Key Questions to Ask Beforehand?

An assessment of essential considerations for clinicians adopting new DVT tools, focusing on efficacy, safety, and integration into existing protocols to ensure effective and safe adoption.

By Pedram Keshavarz, MD; Jonas Kruse, MD; John M. Moriarty, MD, FSIR; and Mona Ranade, MD

Liver-Directed Interventional Oncology: My Top 5 Technical Pearls

Experts provide their top technical tips for cTACE, portal vein embolization, drug-eluting embolic TACE, radiation segmentectomy, parenchyma-sparing Y-90 with flow diversion, challenging ablations, ablation of poorly visualized hepatic tumors, and treatment of parasitized extrahepatic arteries.

By Thierry de Baere, MD; Nadine Abi-Jaoudeh, MD, FSIR, CCRP; Robert J. Lewandowski, MD; Edward Kim, MD, FSIR; Raul N. Uppot, MD; Amanda Smolock, MD, PhD; David S. Wang, MD, FSIR; and Daniel Sze, MD, PhD

The Battle Against CLI

By John R. Laird Jr, MD, Chief Medical Editor